2020

  1. Tanisa Patcharatrakul, Chatchai Kriengkirakul, Tawatchai Chaiwatanarat, and Sutep Gonlachanvit. Acute Effects of Red Chili, a Natural Capsaicin Receptor Agonist, on Gastric Accommodation and Upper Gastrointestinal Symptoms in Healthy Volunteers and Gastroesophageal Reflux Disease Patients. Nutrients. 2020 Dec.
  2. Željko Zubčić, Tihana Mendeš, Andrijana Včeva, Hrvoje Mihalj, Vjeran Bogović, and Stjepan Grga Milanković. Presence of pepsin in laryngeal tissue and saliva in benign and malignant neoplasms. Biosci Rep. 2020 Nov.
  3. Yuji Amano, Norihisa Ishimura, and Shunji Ishihara. Is Malignant Potential of Barrett’s Esophagus Predictable by Endoscopy Findings? Life (Basel). 2020 Oct.
  4. Hidetaka Hamasaki. Effects of Diaphragmatic Breathing on Health: A Narrative Review. Medicines (Basel). 2020 Oct.
  5. Raja Samir Khan, Yousaf Hadi, and Swapna Gayam. Get Me Off This Medication!: A Comparison Between Gastroenterology and Primary Care Regarding Patient’s Perceptions of Proton Pump Inhibitor Therapy. Cureus. 2020 Oct.
  6. Alaa Mohamed, Diego Ochoa Crespo, Gurleen Kaur, Ibtisam Ashraf, Mercedes Maria Peck, Ruchira Maram, and Bilal Haider Malik. Gastroesophageal Reflux and Its Association With Atrial Fibrillation: A Traditional Review. Cureus. 2020 Sep.
  7. Antonio Corsello, Daniela Pugliese, Antonio Gasbarrini and Alessandro Armuzzi. Diet and Nutrients in Gastrointestinal Chronic Diseases. Nutrients. 2020 Sep.
  8. Aamir N. Dam and Jason Klap. A narrative review of Barrett’s esophagus in 2020, molecular and clinical update. Ann Transl Med. 2020 Sep.
  9. Roxanne Cooksey, Jonathan Kennedy, Michael S. Dennis et al. Proton pump inhibitors and dementia risk: Evidence from a cohort study using linked routinely collected national health data in Wales, UK. PLoS One. 2020.
  10. Mohamed Eisa, Annumeet Sandhu, Ravi Prakash, Stephen J Ganocy, and Ronnie Fass. The Risk of Acute Myocardial Infarction in Patients With Gastroesophageal Reflux Disease. J Neurogastroenterol Motil. 2020 Sep.
  11. Shajan Peter, Amanda Pendergraft, William VanDerPol, C. Mel Wilcox, Kondal R. Kyanam Kabir Baig, Casey Morrow, Jacques Izard and Peter J. Mannon. Mucosa-Associated Microbiota in Barrett’s Esophagus, Dysplasia, and Esophageal Adenocarcinoma Differ Similarly Compared With Healthy Controls. Clin Transl Gastroenterol. 2020 Aug.
  12. Nathan Earl Rainey, Aoula Moustapha and Patrice Xavier Petit. Curcumin, a Multifaceted Hormetic Agent, Mediates an Intricate Crosstalk between Mitochondrial Turnover, Autophagy, and Apoptosis. Oxid Med Cell Longev. 2020 Jul.
  13. Bingjing Zheng and David Julian McClements. Formulation of More Efficacious Curcumin Delivery Systems Using Colloid Science: Enhanced Solubility, Stability, and Bioavailability. Molecules. 2020 June.
  14. Lina Elsalem, Ahmad A Jum’ah, Mahmoud A Alfaqih, and Osama Aloudat. The Bacterial Microbiota of Gastrointestinal Cancers: Role in Cancer Pathogenesis and Therapeutic Perspectives. Clin Exp Gastroenterol. 2020 May.
  15. Jorabar Singh Nirwan, Syed Shahzad Hasan, Zaheer-Ud-Din Babar, Barbara R. Conway, and Muhammad Usman Ghori. Global Prevalence and Risk Factors of Gastro-oesophageal Reflux Disease (GORD): Systematic Review with Meta-analysis. Sci Rep. 2020 Apr.
  16. Shahid Ahmed, Sajjad Jamil, Hafeezullah Shaikh, and Maryam Abbasi. Effects of Life style factors on the symptoms of gastro esophageal reflux disease: A cross sectional study in a Pakistani population. Pak J Med Sci. 2020 Jan-Feb.
  17. Tae-Heum Chung, Jiho Lee, In-Du Jeong, and Kun-Chul Lee. Effect of Weight Changes on the Development of Erosive Esophagitis. Korean J Fam Med. 2020 Jan.
  18. Jens Brown; Carl Shermetaro. Laryngopharyngeal Reflux. Treasure Island (FL): StatPearls Publishing; 2020 Jan.
  19. Ali M Kariri, Mohammad A Darraj, Almonther Wassly, Hassan A Arishi, Majid Lughbi, Alhassan Kariri, Abdullah M Madkhali, Musab I Ezzi, and Basim Khawaji. Prevalence and Risk Factors of Gastroesophageal Reflux Disease in Southwestern Saudi Arabia. Cureus. 2020 Jan.
  20. Young Ju Lee, Jiyoon Kwon, Sanggyeong Shin, Young-Gyu Eun, Jae Ho Shin, and Gi-Ja Lee. Optimization of Saliva Collection and Immunochromatographic Detection of Salivary Pepsin for Point-of-Care Testing of Laryngopharyngeal Reflux. Sensors (Basel). 2020 Jan.
  21. Dushyant Kumar, Ali Zifan, Gary Ghahremani, David C Kunkel, Santiago Horgan, and Ravinder K Mittal.Morphology of the Esophageal Hiatus: Is It Different in 3 Types of Hiatus Hernias? J Neurogastroenterol Motil. 2020 Jan.

2019

  1. Nuria Eguaras, Elena Sonsoles Rodríguez-López, Olga Lopez-Dicastillo, M. Ángeles Franco-Sierra, François Ricard and Ángel Oliva-Pascual-Vaca. Effects of Osteopathic Visceral Treatment in Patients with Gastroesophageal. Reflux: A Randomized Controlled Trial, J Clin Med. 2019 Oct.
  2. Jerome R Lechien, Francois Mouawad, F, et al. Treatment of laryngopharyngeal reflux disease: A systematic review. World J Clin Cases. 2019 Oct.
  3. Carolyn Newberry and Kristle Lynch. The role of diet in the development and management of gastroesophageal reflux disease: why we feel the burn, J Thorac Dis. 2019 Aug.
  4. Wei-Yi Lei, Wei-Chuan Chang, Shu-Hui Wen, Chih-Hsun Yi, Tso-Tsai Liu, Jui-Sheng Hung, Ming-Wun Wong, Chien-Lin Chen. Predicting factors of recurrence in patients with gastroesophageal reflux disease: a prospective follow-up analysis. Therap Adv Gastroenterol. Jul 2019.
  5. Pin-Chieh Wu, Yan-Hua Chen, Fu-Zong Wu, Kung-Hung Lin, Chiao-Lin Hsu, Chi-Shen Chen, Yu-Hsun Chen, Po-Hsiang Lin, Guang-Yuan Mar, and Hsien-Chung Yu. Risk factors for Barrett’s esophagus in young adults who underwent upper gastrointestinal endoscopy in a health examination center. Therap Adv Gastroenterol. 2019 Jun.
  6. Sergey Morozov, Vasily Kropochev, and Vasily Isakov. Gastroesophageal Reflux Type and Number Correlate with Nutritional Patterns. Curr Dev Nutr. 2019 Jun.
  7. Conor Slattery, Paul D. Cotter and Paul W. O’Toole. Analysis of Health Benefits Conferred by Lactobacillus Species from Kefir. Nutrients. 2019 Jun.
  8. Martínez-Hurtado, D. Arguisuelas, P. Almela-Notari, X. Cortés, A. Barrasa-Shaw, J. C. Campos-González, J. F. Lisón. Effects of diaphragmatic myofascial release on gastroesophageal reflux disease: a preliminary randomized controlled trial. Sci Rep. May 2019.
  9. Benjamin Ka Seng Thong, Soelaiman Ima-Nirwana, Kok-Yong Chin. Proton Pump Inhibitors and Fracture Risk: A Review of Current Evidence and Mechanisms Involved. Int J Environ Res Public Health. May 2019.
  10. Qing-Hua Sun, Hong-Yan Wang, Shi-Dong Sun, Xin Zhang, and Han Zhang. Beneficial effect of probiotics supplements in reflux esophagitis treated with esomeprazole: A randomized controlled trial. World J Gastroenterol. 2019 May 7; 25(17): 2110–2121.
  11. Maimaiti Yisireyili, Wubulikasimu Wulamu, Aikebaier Aili, Yiliang Li, Aziguli Alimujiang, Aliyeguli Aipire, Maimaitiaili Aizezi, Weimin Zhang, Zhengyi Cao, Abulajiang Mijiti, and Kelimu Abudureyimu. World J Gastroenterol. 2019 May 7; 25(17): 2110–2121. Chronic restraint stress induces esophageal fibrosis with enhanced oxidative stress in a murine model. Exp Ther Med. 2019 Aug.
  12. Yan Xie, Benjamin Bowe, Yan Yan, Hong Xian, Tingting Li, Ziyad Al-Aly. Estimates of all cause mortality and cause specific mortality associated with proton pump inhibitors among US veterans: cohort study. BMJ May 2019.
  13. Santé Canada, Inhibiteurs de la pompe à protons : risque de fractures osseuses, sur http://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2013/26523a-fra.php#media-medias, consulté le 01-05-2019.
  14. Centre de médecine intégré, Relâchement myofascial: symptômes et traitements, https://www.cliniquecmi.com/nos-traitements/physiotherapie-relachement-myofascial/, consulté le 01-07-2019.
  15. Slawomir Kwiecien, Marcin Magierowski, Jolanta Majka, Agata Ptak-Belowska, Dagmara Wojcik, Zbigniew Sliwowski, Katarzyna Magierowska, and Tomasz Brzozowski. Curcumin: A Potent Protectant against Esophageal and Gastric Disorders. Int J Mol Sci. 2019 Mar
  16. Emily Hart, Terry E. Dunn, Steven Feuerstein, David M. Jacobs. Proton Pump Inhibitors and Risk of Acute and Chronic Kidney Disease: A Retrospective Cohort Study. 18 February 2019. 
  17. Mackinzie McDaniel and Richard M. Conran. Educational Case: Barrett Esophagus. Acad Pathol. 2019 Jan-Dec.
  18. Hyo-Joon Yang, Yoosoo Chang, Soo-Kyung Park, Yoon Suk Jung, Jung Ho Park, Dong Il Park, Seungho Ryu and Chong. Sex Differences in the Relation between Waist Circumference within the Normal Range and Development of Reflux Esophagitis. J Clin Med. 2019 Jan.

2018

  1. Agence nationale de sécurité du médicament et des produits de santé (ANSM), Utilisation des inhibiteurs de la pompe à protons. Étude observationnelle à partir des données du SNDS, France, 2015. Rapport décembre 2018.
  2. Scott Klenzak, Igor Danelisen, Grace D Brannan, Melissa A Holland, and Miranda AL van Tilburg. Management of gastroesophageal reflux disease: Patient and physician communication challenges and shared decision making. World J Clin Cases. 2018 Dec.
  3. John M. Inadomi and Nina Saxena. Endoscopic surveillance or ablation for Barrett’s esophagus? Transl Gastroenterol Hepatol. 2018 Dec.
  4. Ki Bae Bang and Jung Ho Park. Weight Loss as a Nonpharmacologic Strategy for Erosive Esophagitis: A 5-Year Follow-up Study. Gut Liver. 2018 Nov.
  5. Prashanth Rawla and Adam Barsouk. Epidemiology of gastric cancer: global trends, risk factors and prevention. Prz Gastroenterol. 2018 Nov.
  6. Yamasaki T., Hemond C., Eisa M., Stephen Ganocy S.,Ronnie Fass R. The Changing Epidemiology of Gastroesophageal Reflux Disease: Are Patients Getting Younger? J Neurogastroenterol Motil. 2018 Oct.
  7. Yen-Chun Peng, Cheng-Li Lin, Wan-Yun Hsu, I-Ta Lu, Hong-Zen Yeh, Chi-Sen Chang and Chia-Hung Kao. Proton Pump Inhibitor Use is Associated With Risk of Pancreatic Cancer: A Nested Case–Control Study. Dose Response. 2018 Oct-Dec.
  8. Brett MacFarlane. Rubenstein. Management of gastroesophageal reflux disease in adults: a pharmacist’s perspective. Integr Pharm Res Pract. 2018 Jun.
  9. Mousalreza Hosseini, Roshanak Salari, Mina Akbari Rad, Maryam Salehi, Batul Birjandi and Masoumeh Salari. Comparing the Effect of Psyllium Seed on Gastroesophageal Reflux Disease With Oral Omeprazole in Patients With Functional Constipation. J Evid Based Integr Med. 2018 Apr.
  10. Eusebi LH, Ratnakumaran R, Yuan Y, Solaymani-Dodaran M, Bazzoli F, Ford AC. Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis. Gut. 2018 Mar.
  11. Schlottmann F., Molena D., Patti M.G. Gastroesophageal reflux and Barrett’s esophagus: A pathway to esophageal adenocarcinoma. Updates Surg. 2018.
  12. Yang J, Dehom S, Sanders S, Murry T, Krishna P, Crawley BK. Treating laryngopharyngeal reflux: Evaluation of an anti-reflux program with comparison to medications. Am J Otolaryngol. 2018;
  13. Joel E. Richter and Joel H. Rubenstein. Presentation and Epidemiology of Gastroesophageal Reflux Disease. Gastroenterology. 2018 Jan.

2017

  1. Hiroshi Kishikawa, Kayoko Kimura, Asako Ito, Kyoko Arahata, Sakiko Takarabe, Shogo Kaida, Takanori Kanai, Soichiro Miura, and Jiro Nishida. Association between Increased Gastric Juice Acidity and Sliding Hiatal Hernia Development in Humans. PLoS One. 2017 Jan.
  2. Dominik Linz, Mathias Hohl, Johanna Vollmar, Christian Ukena, Felix Mahfoud, Michael Böhm. Atrial fibrillation and gastroesophageal reflux disease: the cardiogastric interaction. EP Europace, Jan 2017.
  3. Ka Shing Cheung, Esther W Chan, Angel Y S Wong, Lijia Chen, Ian C K Wong, Wai Keung Leung. Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study. Gut. 2017 Oct. 
  4. Michael F. Vaezi, John E. Pandolfino, Marcelo F. Vela, Nicholas J. Shaheen et al. White Paper AGA: Optimal Strategies to Define and Diagnose Gastroesophageal Reflux Disease. Gastroenterology, 2017, Volume 15, Issue 8, Pages 1162–1172.
  5. Michael F. Vaezi, Yu-Xiao Yang, Colin W. Howden et al. Complications of Proton Pump Inhibitor Therapy. Gastroenterology, 2017, Volume 153, Issue 1, Pages 35–48.
  6. Andrew M. Ong, Laura Chua, Yu Tien Wang et al. Diaphragmatic Breathing Exercises is Efficacious in the Treatment of Belching and Reflux Symptoms in Gerd Patients. 2017; Gastroenterology, Volume 152, Issue 5, Supplement 1, Page S63.
  7. David Mitchell, Mohammad H. Derakhshan, Angela Wirz, Stuart A. Ballantyne, Kenneth E. McColl et al. Abdominal Compression by Waist Belt Aggravates Gastroesophageal Reflux Mainly by Impairing Esophageal Clearance. 2017; Gastroenterology, Vol. 152, Issue 5, S196–S197.
  8. Visweswara Rao Pasupuleti, Lakhsmi Sammugam, Nagesvari Ramesh, Siew Hua Gan. Honey, Propolis, and Royal Jelly: A Comprehensive Review of Their Biological Actions and Health Benefits. Oxid Med Cell Longev. 2017.

2016

  1. Schumock, G.T., Li, E.C., Suda, K.J. et al. National trends in prescription drug expenditures and projections for 2016. Am J Health Syst Pharm. 2016.
  2. M. Trousselard, Canini, D. Claverie, C. Cungi, B. Putois, and N. Franck. Cardiac Coherence Training to Reduce Anxiety in Remitted Schizophrenia, a Pilot Study. Appl Psychophysiol Biofeedback. 2016.
  3. Chien-Hua Chen, Cheng-Li Lin and Chia-Hung Kao. Association between gastroesophageal reflux disease and coronary heart disease. Medicine (Baltimore). 2016.
  4. Herregods T, Van Hoeij F,Oors J, Bredenoord A, Smout A. Effect of Running on Gastroesophageal Reflux and Reflux Mechanisms. – The American Journal of Gastroenterology. 2016.
  5. Eivind Ness-Jensen, Kristian Hveem, Hashem El-Serag, Jesper Lagergren et al. Lifestyle Intervention in Gastroesophageal Reflux Disease. 2016; Clinical Gastroenterology and Hepatology, Vol. 14, Issue 2, p175–182.e3.
  6. Benjamin Lazarus, MBBS1,2; Yuan Chen, MS1; Francis P. Wilson, MD, MS3; et al (2016)Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease. JAMA Intern Med. 2016.
  7. Willy Gomm; Klaus von Holt, MD; Friederike Thomé; et al. Association of Proton Pump Inhibitors With Risk of Dementia. JAMA Neurol. 2016.
  8. Dam G, Vilstrup H, Watson H, Jepsen P. Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites.Hepatology 2016.
  9. Gomm, W., Holt, von, K., Thomé, F., Broich, K., Maier, W., Fink, A., Doblhammer, G., Haenisch, B., (2016). Association of Proton Pump Inhibitors With Risk of Dementia: A Pharmacoepidemiological Claims Data Analysis. JAMA Neurol 73, 410–416.
  10. Dam G, Vilstrup H, Watson H, Jepsen P4. Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites. Hepatology. 2016 Oct.
  11. Kasia Kines and Tina Krupczak. Nutritional Interventions for Gastroesophageal Reflux, Irritable Bowel Syndrome, and Hypochlorhydria: A Case Report. Integr Med (Encinitas). 2016 Aug.
  12. William Krause, Jennifer Roberts and Romel J. Garcia-Montilla. Bowel in Chest: Type IV Hiatal Hernia. Clin Med Res. 2016 Jun; 14(2): 93–96.
  13. Floris Imhann, Marc Jan Bonder, Arnau Vich Vila, Jingyuan Fu, Zlatan Mujagic, Lisa Vork, Ettje F Tigchelaar, Soesma A Jankipersadsing, Maria Carmen Cenit, Hermie J M Harmsen, Gerard Dijkstra, Lude Franke, Ramnik J Xavier, Daisy Jonkers, Cisca Wijmenga, Rinse K Weersma, Alexandra Zhernakova.Proton pump inhibitors affect the gut microbiome.Gut. 2016 May.
  14. Souza R.F. From reflux esophagitis to esophageal adenocarcinoma. Dig. Dis. 2016.
  15. Eivind Ness-Jensen, Kristian Hveem, Hashem El-Serag, Jesper Lagergren. Lifestyle intervention in gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2016 Feb.
  16. Sabine Roman and Peter J Kahrilas. Best Pract Res Clin Gastroenterol. Mechanisms of Barrett’s esophagus (clinical): LES dysfunction, hiatal hernia, peristaltic defects. Author manuscript; available in PMC 2016 Feb 1. 

2015

  1. Haenisch, B., Holt, von, K., Wiese, B., Prokein, J., Lange, C., Ernst, A., et al. Risk of dementia in elderly patients with the use of proton pump inhibitors. European Archives of Psychiatry and Clinical Neuroscience, 2015.
  2. Jae Jin Hwang, Dong Ho Lee, Hyuk Yoon, Cheol Min Shin,Young Soo Park and Nayoung Kim. Is Atrial Fibrillation a Risk Factor for Gastroesophageal Reflux Disease Occurrence? Medicine (Baltimore). 2015 Oct.
  3. Shah NH, LePendu P, Bauer-Mehren A, Ghebremariam YT et al. Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population. PLoS ONE, 2015.
  4. Kantor, E.D., Rehm, C.D., Haas, J.S. et al. Trends in prescription drug use among adults in the United States from 1999–2012. JAMA. 2015.
  5. Andrew Szilagyi. Adaptation to Lactose in Lactase Non Persistent People: Effects on Intolerance and the Relationship between Dairy Food Consumption and Evaluation of Diseases. Nutrients. 2015 Aug.

2014

  1. Daniel E. Freedberg, Benjamin Lebwohl, and Julian A. Abrams. The impact of proton pump inhibitors on the human gastrointestinal microbiome. Clin Lab Med. 2014 Dec.
  2. Mohit K Turagam and Poonam Velagapudi. Gut To Heart: Acid Reflux Disease In Atrial Fibrillation And The Role Of Proton Pump Inhibitor. J Atr Fibrillation. 2014 Oct-Nov.
  3. Ai Kubo, Gladys Block, Charles P Quesenberry, Patricia Buffler and Douglas. Dietary guideline adherence for gastroesophageal reflux disease. BMC Gastroenterol. 2014 Aug.
  4. Andrea Maria Campagnolo, Jaqueline Priston, Rebecca Heidrich Thoen, Tatiana Medeiros and Aída Regina Assunção. Laryngopharyngeal Reflux: Diagnosis, Treatment, and Latest Research.Int Arch Otorhinolaryngol. 2014 Apr.
  5. Rollin McCraty and Maria A. Zayas. Cardiac coherence, self-regulation, autonomic stability, and psychosocial well-being. Front Psychol. 2014.
  6. Madeline Matar Joseph, Mark S. McIntosh and Christine Marie Joseph. The Effects of Various Comfort Food on Heart Coherence in Adults. Glob Adv Health Med. 2014 Jan
  7. Lødrup A Pottegård J Hallas P Bytze. Use of proton pump inhibitors after antireflux surgery : A nationwide register-based follow-up study. Gut 2014

 

2013

  1. Zhang JX, Ji MY, Song J, Lei HB, Qiu S, Wang J, Ai MH, Wang J, Lv XG, Yang ZR, Dong WG. Proton pump inhibitor for non-erosive reflux disease: a meta-analysis. World J Gastroenterol. 2013 Dec.
  2. Math M. V., Khadkikar R. M., & Kattimani. Honey – A nutrient with medicinal property in reflux oesophagitis. The Indian Journal of Medical Research. 2013 Dec. 
  3. Irene Martinucci, Nicola de Bortoli, Edoardo Savarino, Andrea Nacci et al. Optimal treatment of laryngopharyngeal reflux disease. 2013 Nov.
  4. Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol 2013.
  5. C Bourne B Charpiat N Charhon Effets indésirables émergents des inhibiteurs de la pompe à protons. Presse Med 2013.
  6. Georgios Karamanolis, Dimitrios Polymeros, Konstantinos Triantafyllou, Adam Adamopoulos, Charalampos Barbatzas, Irini Vafiadis and Spiros. Hiatal hernia predisposes to nocturnal gastro-oesophageal reflux. United European Gastroenterol J. 2013 Jun.
  7. Abdellah F., Abderrahim L. A. Honey in Traditional and Modern Medicine. Boca raton, Florida, USA: CRC Press; 2013. 8 honey for gastrointestinal.

2012

  1. Janarthanan S et al. Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a metaanalysis. Am J Gastroenterol. 2012 Jul.
  2. Kwok CS et al. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: metaanalysis. Am J Gastroenterol. 2012 Jul.
  3. Chin-Chou Huang, Wan-Leong Chan, Jiing-Chyuan Luo, Yu-Chun Chen, Tzeng-Ji Chen, Chia-Min Chung et al. Gastroesophageal Reflux Disease and Atrial Fibrillation: A Nationwide Population-Based Study. PLoS One. 2012.
  4. Poonam Velagapudi, Mohit K Turagam, Miguel A Leal and Abraham G Kocheril. Atrial Fibrillation and Acid Reflux Disease. Clin Cardiol. 2012 Mar.
  5. Keszthelyi D, Dackus GH, Masclee GM, Kruimel JW, Masclee AA. Increased proton pump inhibitor and NSAID exposure in irritable bowel syndrome: results from a case-control study. BMC Gastroenterol. 2012.

2011

  1. Storr MA. What is nonacid reflux disease? Can J Gastroenterol. 2011 Jan. 
  2. Ronnie Fass. Alternative Therapeutic Approaches to Chronic Proton Pump Inhibitor Treatment. 2011; Clinical Gastroenterology and Hepatology, Vol. 10, Issue 4, p338–345.
  3. Patrick L. Gastroesophageal reflux disease (GERD): A review of conventional and alternative treatments. Altern. Med. Rev. 2011.
  4. Ulluwishewa D, Anderson RC, McNabb WC, Moughan PJ, Wells JM, Roy NC. Regulation of tight junction permeability by intestinal bacteria and dietary components. J Nutr. 2011.

2010

  1. MD Howell V Novack P Grgurich Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. Arch Intern Med 2010.
  2. Matthew R Bower, Harini S Aiyer, Yan Li, and Robert CG Martin. Chemoprotective effects of curcumin in esophageal epithelial cells exposed to bile acids. World J Gastroenterol. 2010 Sep.
  3. Lips P, Bouillon R, et al. Reducing fracture risk with calcium and vitamin D.  Clin Endocrinol (Oxf). 2010 Sep.
  4. DIPART (Vitamin D Individual Patient Analysis of Randomized Trials) Group.Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe.  BMJ. 2010 Jan.
  5. Lombardo L, Foti M, Ruggia O, Chiecchio A. Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy. Clin Gastroenterol Hepatol. 2010.
  6. Keszthelyi D, Jansen SV, Schouten GA, et al. Proton pump inhibitor use is associated with an increased risk for microscopic colitis: a case-control study. Aliment Pharmacol Ther. 2010.

 

2009

  1. T Ali DN Roberts WM. Tierney Long-term safety concerns with proton pump inhibitors. Am J Med 2009 (122).
  2. Festi D ,Scaioli E, Baldi F et al. Body weight, lifestyle, dietary habits and gastroesophageal reflux disease. World J Gastroenterol 2009.
  3. Rafiee P., Nelson V.M., Manley S., Wellner M., Floer M., Binion D.G., Shaker R. Effect of curcumin on acidic pH-induced expression of IL-6 and IL-8 in human esophageal epithelial cells (HET-1A): Role of PKC, MAPKs and NF-kappaB. Am. J. Physiol. Gastrointest. Liver Physiol. 2009.
  4. Bischoff-Ferrari HA, Dawson-Hughes B, et al. BMJ. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. 2009 Oct 1.
  5. Avenell A, Gillespie WJ, et al. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis.  Cochrane Database Syst Rev. 2009 Apr 15. 
  6. Bischoff-Ferrari HA, Willett WC, et al. Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med. 2009 Mar 23.
  7. Mahattanadul S., Nakamura T., Panichayupakaranant P., Phdoongsombut N., Tungsinmunkong K., Bouking P. Comparative antiulcer effect of bisdemethoxycurcumin and curcumin in a gastric ulcer model system. Phytomedicine. 2009.
  8. Peter J. Kahrilas, Hyon C. Kim and John E Pandolfino .Approaches to the Diagnosis and Grading of Hiatal Hernia. Best Pract Res Clin Gastroenterol 2009 Jan 1.
  9. NJ Shaheen MF Vaezi. American Gastroenterological Association medical position statement on the management of gastroesophageal reflux disease. Gastroenterology 2009. 

2007

  1. J Leonard JK Marshall P. Moayyedi Systematic review of the risk of enteric infection in patients taking acid suppression. Am J Gastroenterol 2007.
  2. Jozkow P,Wasko-Czopnik D, Dunajska K et al. The relationship between gastroesophageal reflux disease and the level of physical activity. Swiss Med Wkly 2007.
  3. Cranney A, Horsley T, et al. Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep). 2007 Aug.
  4. Chen TC, Chimeh F, et al. Factors that influence the cutaneous synthesis and dietary sources of vitamin D. Arch Biochem Biophys. 2007 Apr.
  5. Jackson C, Gaugris S, et al. The effect of cholecalciferol (vitamin D3) on the risk of fall and fracture: a meta-analysis.  QJM. 2007 Apr.
  6. Mullin JM, Valenzano MC, Whitby M, et al. Esomeprazole induces upper gastrointestinal tract transmucosal permeability increase. Aliment Pharmacol Ther. 2007.

2006

  1. Pandolfino J.E., El-Serag H.B., Zhang Q., Shah N., Ghosh S.K., Kahrilas P.J. Obesity: A challenge to esophagogastric junction integrity. Gastroenterology. 2006;130:639–649. 
  2. Mahattanadul S., Radenahmad N., Phadoongsombut N., Chuchom T., Panichayupakaranant P., Yano S., Reanmongkol W. Effects of curcumin on reflux esophagitis in rats. J. Nat. Med. 2006;60:198–205. 

2005

  1. Costa H.O. et al.: Is there a relationship between the pH and volume of saliva and oesophageal pH-metry results. Dysphagia, 2005.
  2. Dent J, El-Serag HB, Wallander MA et al. Epidemiology of gastro-oesophageal reflux disease: a systematic review.Gut 2005
  3. El-Serag, H., Satia, J., Rabeneck, L. (2005) Dietary intake and the risk of gastro-oesophageal reflux disease: a cross sectional study in volunteers. Gut 54: 11–17.
  4. Jiménez P. et al.: Free radicals and antioxidant in reflux esophagitis and Barrett’s esophagus. World J Gastroenterol 2005 May.
  5. Pilar Jiménez, Elena Piazuelo, M. Teresa Sánchez, Javier Ortego, Fernando Soteras, and Angel Lanas. Free radicals and antioxidant systems in reflux esophagitis and Barrett’s esophagus. World J Gastroenterol. 2005 May.
  6. S Dial JAC Delaney AN Barkun Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 2005.
  7. Ravi N, Stuart RC, Byrne PJ et al. Effect of physical exercise on esophageal motility in patients with esophageal disease. Dis Esophagus 2005.

2004

  1. Laheij RJF, Sturkenboom MCJM, Hassing RJ, et al. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA 2004.
  2. Parmelee-Peters K, Moeller JL. Gastroesophageal reflux in athletes. Curr Sports Med Rep 2004.
  3. Pan do li no JE, Bianchi LK,Lee TJ et al. Esophagogastric junction morpho-logy predicts susceptibility to exercise-induced reflux. Am J Gastroenterol 2004.
  4. Nilsson, M., Johnsen, R., Ye, W., Hveem, K., Lagergren, J. Lifestyle related risk factors in the aetiology of gastro-oesophageal reflux. Gut 2004.
  5. Meineche-Schmidt V, Juhl HH, Ostergaard JE, Luckow A, Hvenegaard A. Costs and efficacy of three different esomeprazole treatment strategies for long-term management of gastro-oesophageal reflux symptoms in primary care. Aliment Pharmacol Ther. 2004 Apr.

2003

  1. Malabanan AO, Holick MF. Vitamin D and bone health in postmenopausal women. J Womens Health (Larchmt). 2003 Mar.
  2. Derek D. Schramm, Malina Karim, Heather R. Schrader, Roberta R. Holt, Marcia Cardetti, Carl L. Keen. Honey with High Levels of Antioxidants Can Provide Protection to Healthy Human. American Chemical Society Subjects. 2003 Feb.

 

  1. Nele Gheldof, Xiao-Hong, Wang Nicki J. Engeseth. Buckwheat Honey Increases Serum Antioxidant Capacity in Humans. American Chemical Society. 2003 Jan.
  2. Collings KL, Pierce Pratt F,Rodriguez-Stanley S et al. Esophageal reflux in conditioned runners, cyclists, and weightlifters. Med Sci Sports Exerc 2003.
  3. Servan-Schreiber, D. Guérir le stress, l’anxiété et la dépression sans médicaments. 2003.

2001

  1. Terry, P., Lagergren, J., Ye, W., Wolk, A., Nyren, O. (2001) Inverse association between intake of cereal fiber and risk of gastric cardia cancer. Gastroenterology 120: 387–391.
  2. Armstrong D, Pare P, Pericak D, Pyzyk M, Canadian Pantoprazole GERD Study Group. Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease. Am J Gastroenterol. 2001 Oct.

 

2000

  1. Cats, A., Schenk, B.E., Bloemena, E. et al. Parietal cell protrusions and fundic gland cysts during omeprazole maintenance treatment. Hum Pathol. 2000; 31: 684–690.

Avant 2000

  1. Yazaki E, Shawdon A, Beasley I et al. The effect of different types of exercise on gastro-oesophageal reflux.Aust J Sci Med Sport 1996.
  2. A Tiller, R McCraty, M Atkinson. Cardiac coherence: a new, noninvasive measure of autonomic nervous system order. Altern Ther Health Med. 1996 Jan.
  3. Soffer EE, Wilson J, Duethman G et al. Effect of graded exercise on esophageal motility and gastroesophageal reflux in nontrained subjects.Dig Dis Sci 1994.
  4. Soffer EE, Merchant RK, Duethman G et al. Effect of graded exercise on esophageal motility and gastroesophageal reflux in trained athletes. Dig Dis Sci 1993.
  5. Worme JD,Doubt TJ,Singh A et al. Dietary patterns, gastrointestinal complaints, and nutrition knowledge of recreational triathletes. Am J Clin Nutr 1990.
  6. Kraus BB, Sinclair JW, Castell DO. Gastroesophageal reflux in runners. Characteristics and treatment. Ann Intern Med 1990.
  7. Clark CS, Kraus BB,Sinclaire J et al. Gastroesophageal reflux induced by exercise in healthy volunteers. JAMA 1989.
  8. Worobetz LJ, Gerrard DF. Gastrointestinal symptoms during exercise in Enduro athletes: prevalence and speculations on the aetiology. NZ Med J 1985.
  9. Charles J. Sigmund, Edmund F. McNally et al. The Action of a Carminative on the Lower Esophageal Sphincter. 1969; Gastroenterology, Vol. 56, Issue 1, p13–18.